How do you accurately analyse All of the drugs that are being developed When in every 20 Only one will make it to the market place ?
Evaluate Omnium
All Data and Features Available in Evaluate Omnium
Success Rates
Predicts which in-house or competitor drugs are most likely to reach the market, so you can compare risk levels across products or indications. Includes product-specific probability of technical and regulatory success (PTRS), fully transparent risk audits and success rate benchmarks.
Request Your Free Trial
Development Timelines
Predicts when key development milestones will occur, so you can track progress against competitors or highlight products with first-in-class potential. Includes time-in-phase, launch date and market entry order predictions, as well as recruitment timeline benchmarks.
Request Your Free Trial
R&D Costs
Provides the industry’s first comprehensive clinical trial costing model, applying real-world data to over 50,000 trials, so you can better assess likely costs across the development cycle. Includes estimated, product-level trial costs for past and current clinical trials, future R&D cost predictions and industry benchmarks by indication.
Request Your Free Trial
Clinical Trials
Tracks and integrates clinical trials from three key industry sources alongside key commercial insights, so you can fully understand company development plans and pipelines.
Request Your Free Trial
Predictive Clinical Trial Design
Predicts the future patient enrolment needed to successfully complete clinical development, so you can determine trial resources needed, alongside historical benchmarks by phase and indication.
Request Your Free Trial
Clinical Outcomes
Aggregates and standardises clinical trial outcomes for indications and products so you can stay informed on trial results, updated daily and focused on the indication-specific endpoints most likely to lead to regulatory approval.
Request Your Free Trial
Calendar of Events
Identifies and tracks critical product lifecycle and company events, such as trial initiations, regulatory decisions and financial results, so you can stay informed on key market catalysts or competitor activities.
Request Your Free Trial
NPV (Net Present Value) Analyzer
Calculates a product’s Net Present Value (NPV) using a interactive model based on discounted cash flow models to 2040 for over 6,000 products, with editable inputs so you can create custom models.
Request Your Free Trial
NPV by Indication
Extends Evaluate Omnium's NPV Analyzer model to the indication level, with increased granularity on inputs and cashflow by indication, improving your understanding of product value drivers.
Request Your Free Trial
Predicted Peak Sales
Delivers an independent, balanced view of asset potential with comprehensive coverage across all phases of the clinical lifecycle, including early-stage and privately-owned drugs, so you can identify the products with the greatest commercial potential.
Request Your Free Trial
Market Dynamics
Provides time-to-peak analysis so you can better assess a drug’s market impact or improve product launch planning. Includes US time-to-peak benchmarks by indication, market exclusivity impact and time-to-peak values for historically launched drugs.
Request Your Free Trial
Pricing
Aggregates key pricing data, so you have easy access to consolidated, standardised US pack pricing for approved products, current cost-per-patient values for launched products and benchmarks for annual cost-per-patient by indication and technology.
Request Your Free Trial
Market Access
Provides unique formulary access scores to help you identify the current market access position for products launched in the US, with benchmarks by EphMRA code, technology and mechanism of action.
Request Your Free Trial
Unmet Needs
Quantifies and compares the degree of unmet need across indications, so you can better focus portfolio investments on therapeutic areas that could have the greatest impact to patients.
Request Your Free Trial
Risk-Adjusted Peak Sales
Combines the improved accuracy of our Product Specific PTRS and Predicted Peak Sales analytics, so you have a single metric for forecasting the commercial potential of pharma assets across all phases of clinical development.
Request Your Free Trial
Side-by-Side Comparisons
Combines Evaluate Omnium's risk and return data in unique, interactive visualisations, so you can quickly and efficiently compare products based on consistent, proven methodologies.
Request Your Free Trial
Risk and return combined
Evaluate Omnium’s proprietary functionality and analytics, many of which are brand new to the market, cover the full product lifecycle. By bringing together the full depth and breadth of Evaluate’s unrivalled risk and return data in a single product, Evaluate Omnium provides a more accurate, impartial and timely view of pharma asset potential.
